As of Nov 27
| -0.09 / -0.11%|
The 20 analysts offering 12-month price forecasts for Eli Lilly and Co have a median target of 93.00, with a high estimate of 121.00 and a low estimate of 75.00. The median estimate represents a +11.18% increase from the last price of 83.65.
The current consensus among 22 polled investment analysts is to Buy stock in Eli Lilly and Co. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.